Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Liabilities and Shareholders Equity (2016 - 2025)

Alkermes (ALKS) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $2.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 20.99% to $2.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $9.2 billion, a 7.14% increase, with the full-year FY2025 number at $2.5 billion, up 20.99% from a year prior.
  • Liabilities and Shareholders Equity was $2.5 billion for Q4 2025 at Alkermes, up from $2.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.5 billion in Q4 2025 to a low of $1.9 billion in Q1 2021.
  • A 5-year average of $2.1 billion and a median of $2.1 billion in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 5.44% in 2024, then increased 20.99% in 2025.
  • Alkermes' Liabilities and Shareholders Equity stood at $2.0 billion in 2021, then fell by 2.99% to $2.0 billion in 2022, then grew by 8.77% to $2.1 billion in 2023, then fell by 3.78% to $2.1 billion in 2024, then grew by 20.99% to $2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Liabilities and Shareholders Equity are $2.5 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.3 billion (Q2 2025).